Experts say the jury is still out on whether TrumpRx will lead to significant savings on drug prices, though it will likely help people who need medications not commonly covered by insurance.
The 2028 negotiation cycle marks another major inflection point in the implementation of the Medicare Drug Price Negotiation Program—its first year incorporating Part B drugs and its first opportunity ...
A phase I dose-escalation and expansion study of JPI-547, a dual inhibitor of PARP/tankyrase in patients with advanced solid tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results